BioStem Technologies, Inc.
BSEM
$3.71
-$0.25-6.22%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -69.87% | 95.53% | 106.60% | 538.87% |
| Total Depreciation and Amortization | -- | 9.48% | -8.34% | -8.34% | 3.05% |
| Total Amortization of Deferred Charges | -- | -83.15% | -73.90% | -73.90% | -12.80% |
| Total Other Non-Cash Items | -- | -22.71% | -31.99% | -31.99% | -48.56% |
| Change in Net Operating Assets | -- | 54.33% | 135.55% | 128.88% | 73.22% |
| Cash from Operations | -- | -52.28% | 270.89% | 270.89% | 974.37% |
| Capital Expenditure | -- | -887.03% | -126.85% | -126.85% | -674.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 209.17% | -1,290.48% | -1,290.48% | -1,287.08% |
| Cash from Investing | -- | -7.73% | -586.58% | -586.58% | -2,847.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 2.63% | 18.61% | 18.61% | 62.39% |
| Issuance of Common Stock | -- | -97.89% | -94.09% | -94.09% | -94.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -198.27% | -169.87% | -169.87% | -111.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -70.18% | 156.91% | 156.91% | 3,501.82% |